TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36064215

Group type: EXPERIMENTAL
Intervention: ISF schools
Number of subjects: 24

Group type: COMPARATOR
Intervention: PBIS+SMH schools
Number of subjects: 24
Study: 34390930

Group type: EXPERIMENTAL
Intervention: Adaptive camouflage training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Massed camouflage training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control (no camouflage)
Number of subjects: 0
Study: 35445052

Group type: EXPERIMENTAL
Intervention: Roxadustat (initial dose of 70 or 100 mg three times a week)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Erythropoietin (subcutaneous injection for 24 weeks to maintain hemoglobin ranging from 100 to 120 g per liter)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 68

Group type: COMPARATOR
Intervention: Erythropoietin
Number of subjects: 68
Study: 32168216

Group type: EXPERIMENTAL
Intervention: Cephalic elevation device inflation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cephalic elevation device non-inflation (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (inflation and non-inflation)
Number of subjects: 60
Study: 36332136

Group type: EXPERIMENTAL
Intervention: Probiotic supplement (1 capsule/day for 8 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Probiotic supplement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32948471

Group type: EXPERIMENTAL
Intervention: Prediction equation model of AMM using weight, sex, height, and handgrip strength as independent variables
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: Predicted AMM
Number of subjects: 1020

Group type: COMPARATOR
Intervention: BIA-measured LM
Number of subjects: 1020

Group type: COMPARATOR
Intervention: DXA-measured AMM
Number of subjects: 1020
Study: 32737141

Group type: EXPERIMENTAL
Intervention: Metabolic surgery (bariatric surgery)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Gastric bypass surgery
Number of subjects: 73

Group type: COMPARATOR
Intervention: Oral glucose tolerance test (OGTT)
Number of subjects: 73
Study: 36202885

Group type: EXPERIMENTAL
Intervention: Compression tights applied for 4 h (COMP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo tablet consumed every hour for 4 h (PLA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 22
Study: 33629219

Group type: EXPERIMENTAL
Intervention: CBT-I
Number of subjects: 160

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 160
Study: 35486478

Group type: EXPERIMENTAL
Intervention: Oral hormonal contraceptive pill (OC) during high estradiol (HE) phase
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Oral hormonal contraceptive pill (OC) during low estradiol (LE) phase
Number of subjects: 21

Group type: COMPARATOR
Intervention: Natural menstrual cycles (NC) during high estradiol (HE) phase
Number of subjects: 21

Group type: COMPARATOR
Intervention: Natural menstrual cycles (NC) during low estradiol (LE) phase
Number of subjects: 21
Study: 32931763

Group type: EXPERIMENTAL
Intervention: Spinal manipulation therapy (3 sessions, 1 week apart, using Robert Maigne's technique)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Physiotherapy (control group)
Number of subjects: 44
Study: 32792454

Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation (TTNS) for 30 minutes/day, 5 days/week, for 6-9 weeks starting within 40 days after SCI.
Number of subjects: 114

Group type: COMPARATOR
Intervention: Sham TTNS (control group).
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: TTNS (intervention).
Number of subjects: 114
Study: 32441852

Group type: EXPERIMENTAL
Intervention: Fast enteral advancement (30 mL/kg/d for 1000-1499 g; 40 mL/kg/d for 1500-1999 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional enteral advancement (20 mL/kg/d)
Number of subjects: 0
Study: 32308126

Group type: EXPERIMENTAL
Intervention: Ischial ramus containment socket
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dynamic socket
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sub-ischial socket
Number of subjects: 0
Study: 36463178

Group type: EXPERIMENTAL
Intervention: CPAP/NIV starting at P/F ≤ 200 (Group A)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: CPAP/NIV starting at P/F ≤ 150 (Group B)
Number of subjects: 146

Group type: COMPARATOR
Intervention: CPAP/NIV starting at P/F ≤ 100 (Group C)
Number of subjects: 146

Group type: COMPARATOR
Intervention: CPAP/NIV starting at P/F between 151 and 200
Number of subjects: 146
Study: 33254171

Group type: EXPERIMENTAL
Intervention: COVID-19 patients with confirmed SARS-CoV-2 infection
Number of subjects: 3
Study: 36254455

Group type: EXPERIMENTAL
Intervention: Brief social contact‐based videos (traditional or selfie styles)
Number of subjects: 1532

Group type: EXPERIMENTAL
Intervention: Traditional videos
Number of subjects: 1532

Group type: EXPERIMENTAL
Intervention: Selfie videos
Number of subjects: 1532

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1532
Study: 34498944

Group type: EXPERIMENTAL
Intervention: Low-intensity aerobic exercise with low-pressure blood flow restriction (BFR40)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-intensity aerobic exercise with high-pressure blood flow restriction (BFR80)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (HI-AE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-intensity aerobic exercise (LI-AE)
Number of subjects: 0
Study: 36357840

Group type: EXPERIMENTAL
Intervention: Exogenous IAA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exogenous ABA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exogenous ABA or IAA
Number of subjects: 0
Study: 36241582

Group type: EXPERIMENTAL
Intervention: Specific training intervention with task interruptions (TI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control training session (without interruption)
Number of subjects: 21
Study: 33219727

Group type: EXPERIMENTAL
Intervention: Endocrown with an empty pulp chamber (EC)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Onlay preparation with EverX Posterior (OE)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Onlay preparation with G‐aenial Universal Flo (OG)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: MOD inlay preparation with EverX Posterior (IE)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: MOD inlay preparation with G‐aenial Universal Flo (IG)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group without access cavity preparation (C)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Onlays with EverX Posterior
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Onlays with G‐aenial Universal Flo
Number of subjects: 180
Study: 32280282

Group type: EXPERIMENTAL
Intervention: EE 20 mcg/DRSP 3 mg in an extended regimen (EE/DRSPes group)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: EE 20 mcg/DRSP 3 mg in an extended regimen with 4-day hormone-free interval
Number of subjects: 348
Study: 35610018

Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Transcutaneous non-auricular vagus nerve stimulation (tnVNS)
Number of subjects: 12
Study: 34708716

Group type: EXPERIMENTAL
Intervention: Downhill running (DR trial, -15% slope) at 60% O2max for 30 min
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Level running (trial) at 60% O2max for 30 min
Number of subjects: 9

Group type: COMPARATOR
Intervention: Rest (CON trial)
Number of subjects: 9
Study: 32195370

Group type: EXPERIMENTAL
Intervention: CureApp Smoking Cessation (CASC) system including a smartphone app, web-based patient management software, and mobile CO checker
Number of subjects: 584

Group type: COMPARATOR
Intervention: Control app without a mobile CO checker
Number of subjects: 584
Study: 33719786

Group type: EXPERIMENTAL
Intervention: Topical glaucoma medications (one-drug, two-drug, three-drug, four-drug regimens)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Topical glaucoma medications
Number of subjects: 95
Study: 32467335

Group type: EXPERIMENTAL
Intervention: BMI ≥30 kg/m²
Number of subjects: 1618
Study: 35562406

Group type: EXPERIMENTAL
Intervention: methotrexate-cytarabine (arm A)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: methotrexate-cytarabine-rituximab (arm B)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: methotrexate-cytarabine-thiotepa-rituximab (MATRix; arm C)
Number of subjects: 219

Group type: COMPARATOR
Intervention: whole-brain irradiation (WBRT)
Number of subjects: 219

Group type: COMPARATOR
Intervention: carmustine-thiotepa-conditioned autologous transplantation (ASCT)
Number of subjects: 219
Study: 34289708

Group type: EXPERIMENTAL
Intervention: Lesion evolution measured by noncontrast CT at 24 hours and 1 week after stroke onset
Number of subjects: 226

Group type: COMPARATOR
Intervention: Successful recanalization (defined as modified Arterial Occlusion Lesion score of 3 points)
Number of subjects: 226
Study: 32232637

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m2, single intravenous infusion)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Prednisone alone (control group)
Number of subjects: 30
Study: 36216005

Group type: EXPERIMENTAL
Intervention: Topical imiquimod
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study: 35248276

Group type: EXPERIMENTAL
Intervention: Soft and prolonged massage with roghan‐i‐suranjan
Number of subjects: 40

Group type: COMPARATOR
Intervention: Short wave diathermy
Number of subjects: 40
Study: 34477026

Group type: EXPERIMENTAL
Intervention: 29°C
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 32°C
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 35°C
Number of subjects: 144

Group type: COMPARATOR
Intervention: 26°C (control)
Number of subjects: 144
Study: 34053177

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily
Number of subjects: 3636

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3636
Study: 32705392

Group type: EXPERIMENTAL
Intervention: Hypoxia (FiO2 = 0.13) during shoulder press in failure sessions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypoxia (FiO2 = 0.13) during shoulder press in non-failure sessions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypoxia (FiO2 = 0.13) during bench press in non-failure sessions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypoxia (FiO2 = 0.13) during non-failure sessions
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normoxia (FiO2 = 0.21)
Number of subjects: 20
Study: 34399358

Group type: EXPERIMENTAL
Intervention: Structured training program of supervised, task‐specific training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no structured training)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Structured training program
Number of subjects: 20
Study: 33682431

Group type: EXPERIMENTAL
Intervention: Trial adjudication and claims
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: Trial adjudication only
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: Claims only
Number of subjects: 1336

Group type: COMPARATOR
Intervention: No ischemic events
Number of subjects: 1336

Group type: COMPARATOR
Intervention: No bleeding events
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: Claims only (no trial-adjudicated events)
Number of subjects: 1336
Study: 32375634

Group type: EXPERIMENTAL
Intervention: Chloroplast transcriptome analysis under drought conditions
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Reverse transcription (RT)-qPCR of 9 cpDEGs
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Phylogenetic analysis using chloroplast genome sequences of 23 Populus plants
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: mVISTA analysis of chloroplast genome
Number of subjects: 1
Study: 35481707

Group type: EXPERIMENTAL
Intervention: TransCon CNP (75-150 μg CNP/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TransCon CNP
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 34293624

Group type: EXPERIMENTAL
Intervention: Guo Qing Yi Tang (GQYT) combined with Western medicine cluster therapy
Number of subjects: 138

Group type: COMPARATOR
Intervention: Cluster therapy alone
Number of subjects: 138
Study: 35072307

Group type: EXPERIMENTAL
Intervention: Propolis
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 35474455

Group type: EXPERIMENTAL
Intervention: Resistance training (RES)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Endurance training (END)
Number of subjects: 86
Study: 34688229

Group type: EXPERIMENTAL
Intervention: McGrath™ MAC videolaryngoscope
Number of subjects: 28

Group type: COMPARATOR
Intervention: Direct laryngoscope
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 28
Study: 34954864

Group type: EXPERIMENTAL
Intervention: Neoadjuvant FOLFOX chemotherapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Immune profiling of primary CRC
Number of subjects: 74
Study: 32778907

Group type: EXPERIMENTAL
Intervention: Active heel-slide exercise (AHSE) + standard physiotherapy (PT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous passive motion (CPM) + standard physiotherapy (PT)
Number of subjects: 0
Study: 35190477

Group type: COMPARATOR
Intervention: Masitinib 4.5 mg/kg/d
Number of subjects: 611

Group type: COMPARATOR
Intervention: Masitinib 6.0 mg/kg/d
Number of subjects: 611

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 611
Study: 32481374

Group type: EXPERIMENTAL
Intervention: Warrior emergency simulator
Number of subjects: 20
Study: 33334174

Group type: EXPERIMENTAL
Intervention: Local ketorolac and Marcaine infiltration
Number of subjects: 80

Group type: COMPARATOR
Intervention: Popliteal nerve block
Number of subjects: 80
Study: 33057344

Group type: EXPERIMENTAL
Intervention: Hybrid seeding approach with n ≤ 256
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: Hybrid seeding approach
Number of subjects: 2001
Study: 34843870

Group type: EXPERIMENTAL
Intervention: Single oral dose of 25 μg of d3‐vitamin D3
Number of subjects: 0
Study: 34894316

Group type: EXPERIMENTAL
Intervention: Structured Postoperative Treatment (SPT)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard Care Approach (SA)
Number of subjects: 154
Study: 32985539

Group type: EXPERIMENTAL
Intervention: Intravenous ferric derisomaltose (1,000 mg)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Intravenous normal saline (control)
Number of subjects: 57
Study: 35398843

Group type: EXPERIMENTAL
Intervention: Auditory Training (AT) program for 8 weeks including sound discrimination and cognitive exercises
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no AT)
Number of subjects: 33
Study: 32717627

Group type: EXPERIMENTAL
Intervention: Mindful Self-Compassion workshop with Facebook group discussion (50-minute workshop)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 76
Study: 36608978

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy for Body Dysmorphic Disorder (CT‐BDD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-list (WL)
Number of subjects: 40
Study: 34301736

Group type: EXPERIMENTAL
Intervention: PPT diet
Number of subjects: 225

Group type: COMPARATOR
Intervention: MED diet
Number of subjects: 225
Study: 33142493

Group type: COMPARATOR
Intervention: Dietary manganese supplementation (20, 40, 80, 120, or 160 mg/kg of Mn as MnSO4·H2O)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Dietary manganese supplementation
Number of subjects: 504
Study: 35242590

Group type: EXPERIMENTAL
Intervention: smartphone-based intervention
Number of subjects: 166

Group type: COMPARATOR
Intervention: goal-setting control group
Number of subjects: 166
Study: 33875484

Group type: EXPERIMENTAL
Intervention: Insulin icodec titration A (prebreakfast self-measured blood glucose target 80-130 mg/dL; adjustment ±21 units/week; n = 51)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Insulin icodec titration B (80-130 mg/dL; ±28 units/week; n = 51)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Insulin icodec titration C (70-108 mg/dL; ±28 units/week; n = 52)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Insulin glargine 100 units/mL (IGlar U100) (80-130 mg/dL; ±4 units/day; n = 51)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Insulin icodec titration B vs IGlar U100
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C, IGlar U100)
Number of subjects: 205
Study: 35749631

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (specific regimens not detailed)
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Oxaliplatin treatment
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Obese/overweight patients
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Younger patients with normal baseline weight
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Older patients
Number of subjects: 1373

Group type: COMPARATOR
Intervention: All treatment arms
Number of subjects: 1373
Study: 34081614

Group type: EXPERIMENTAL
Intervention: Feminizing hormonal treatment (GAHT) including natural estrogen (estradiol) and testosterone-blocking treatments such as cyproterone acetate, GnRH agonist, or spironolactone.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate as anti-androgen treatment.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Natural progesterone as part of GAHT.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orchiectomy after various durations of GAHT.
Number of subjects: 0
Study: 36396162

Group type: EXPERIMENTAL
Intervention: Face‐to‐face presentations, printed information, and additional components
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Reminders and multicomponent strategies including provider-level interventions
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Various interventions that did not lead to improvement in HPV vaccination intention or uptake
Number of subjects: 95
Study: 32873147

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 173

Group type: COMPARATOR
Intervention: No ACE inhibitors
Number of subjects: 173
Study: 36056362

Group type: EXPERIMENTAL
Intervention: EMDR therapy (4 sessions of 90 minutes each, divided over two half-days)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: EMDR therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 14
Study: 33300371

Group type: EXPERIMENTAL
Intervention: Ospemifene 60 mg/day
Number of subjects: 100
Study: 36097258

Group type: EXPERIMENTAL
Intervention: Topical benzyl benzoate (25% or 10%) for daily use over three consecutive days
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Oral ivermectin (200 μg/kg body weight) twice, 1 week apart
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Combination of BB plus ivermectin
Number of subjects: 224

Group type: COMPARATOR
Intervention: Topical benzyl benzoate (BB)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Oral ivermectin
Number of subjects: 224
Study: 33497715

Group type: EXPERIMENTAL
Intervention: JWH-018 (75 μg/kg body weight)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 36063554

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33988306

Group type: EXPERIMENTAL
Intervention: Cannabis-based medicinal products (CBMPs)
Number of subjects: 129
Study: 36079749

Group type: EXPERIMENTAL
Intervention: 60 g date fruit daily for 12 weeks
Number of subjects: 79

Group type: COMPARATOR
Intervention: 60 g raisins daily for 12 weeks
Number of subjects: 79
Study: 34101010

Group type: EXPERIMENTAL
Intervention: Lactoferrin (Lf)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Iron hydroxide polymaltose complex (IPC)
Number of subjects: 66
Study: 36465461

Group type: EXPERIMENTAL
Intervention: Visualizable steerable sheath (SS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-visualizable steerable sheath (SS)
Number of subjects: 100
Study: 32193070

Group type: EXPERIMENTAL
Intervention: Cultural competence education programme (4 units, once weekly for 4 weeks, 3 hours each session)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 97
Study: 35787487

Group type: EXPERIMENTAL
Intervention: MinSafeStart (MSS) mobile app
Number of subjects: 268

Group type: COMPARATOR
Intervention: Standard maternal care
Number of subjects: 268
Study: 34537744

Group type: EXPERIMENTAL
Intervention: Intrathyroid steroid injections
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral prednisone
Number of subjects: 32
Study: 32718924

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose (SMBG) with glucose metre, blood test strips, logbook, waste management box, and training in addition to usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (clinical consultations and routine monthly follow-up)
Number of subjects: 0
Study: 35388281

Group type: EXPERIMENTAL
Intervention: Group B (article plus drawings)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group A (only article)
Number of subjects: 60
Study: 35431754

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 42
Study: 32943115

Group type: EXPERIMENTAL
Intervention: BCG vaccine (0.1 ml of resuspended BCG vaccine administered intradermally)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo (0.1 ml of sterile 0.9% NaCl solution administered intradermally)
Number of subjects: 1500
Study: 35996694

Group type: EXPERIMENTAL
Intervention: Three-dimensional IMRT
Number of subjects: 100

Group type: COMPARATOR
Intervention: Three-dimensional conformal radiotherapy (control)
Number of subjects: 100
Study: 32796456

Group type: EXPERIMENTAL
Intervention: Self-myofascial release therapy using the INYBI tool
Number of subjects: 58

Group type: COMPARATOR
Intervention: Myofascial release therapy (MRT) of the suboccipital muscles
Number of subjects: 58
Study: 34954424

Group type: EXPERIMENTAL
Intervention: Bethanechol (25 mg, 2 times daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bethanechol (for patients receiving 131I dose > 125mCi)
Number of subjects: 50
Study: 32020168

Group type: EXPERIMENTAL
Intervention: Modified dairy diet (SFA-reduced, MUFA-enriched)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional dairy diet (control)
Number of subjects: 54